Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Bates

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|February 23, 2026
Evaluation of <i>Andrographis paniculata</i> in a mouse model of influenza A viral infection using oral administration and a translationally relevant doseKashif Shamim, Grace C Burnett, Jin Zhang, et al.
ACS Applied Bio Materials|September 2, 2022
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 InfectionsAvijit Pramanik, Justin Mayer, Sudarson Sekhar Sinha, et al.
Human Vaccines & Immunotherapeutics|February 16, 2024
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infectionJohn T Bates, Seth T Lirette, Andrew P Farmer, et al.
Journal of Virology|June 13, 2014
STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challengeDaniel E Dulek, Dawn C Newcomb, Shinji Toki, et al.
Viruses|February 24, 2024
Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with HeparinJiyuan Yang, Yuefan Song, Weihua Jin, et al.
ACS Omega|March 7, 2022
Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum DotsAvijit Pramanik, Poonam C Sharma, Shamily Patibandla, et al.
Carbohydrate Polymers|March 13, 2021
Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virusLufeng Yan, Yuefan Song, Ke Xia, et al.
Mabs|February 12, 2013
Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat modelLarry Zeitlin, Ognian Bohorov, Natasha Bohorova, et al.
Vaccine|January 17, 2016
Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primatesJohn T Bates, Jennifer A Pickens, Jennifer E Schuster, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|May 2, 2024
Evidence of SARS-CoV-2 Antibody in Mississippi White-Tailed DeerScoty Hearst, Pedro M Palermo, Douglas M Watts, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|February 23, 2026
Evaluation of <i>Andrographis paniculata</i> in a mouse model of influenza A viral infection using oral administration and a translationally relevant doseKashif Shamim, Grace C Burnett, Jin Zhang, et al.
ACS Applied Bio Materials|September 2, 2022
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 InfectionsAvijit Pramanik, Justin Mayer, Sudarson Sekhar Sinha, et al.
Human Vaccines & Immunotherapeutics|February 16, 2024
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infectionJohn T Bates, Seth T Lirette, Andrew P Farmer, et al.
Journal of Virology|June 13, 2014
STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challengeDaniel E Dulek, Dawn C Newcomb, Shinji Toki, et al.
Viruses|February 24, 2024
Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with HeparinJiyuan Yang, Yuefan Song, Weihua Jin, et al.
ACS Omega|March 7, 2022
Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum DotsAvijit Pramanik, Poonam C Sharma, Shamily Patibandla, et al.
Carbohydrate Polymers|March 13, 2021
Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virusLufeng Yan, Yuefan Song, Ke Xia, et al.
Mabs|February 12, 2013
Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat modelLarry Zeitlin, Ognian Bohorov, Natasha Bohorova, et al.
Vaccine|January 17, 2016
Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primatesJohn T Bates, Jennifer A Pickens, Jennifer E Schuster, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|May 2, 2024
Evidence of SARS-CoV-2 Antibody in Mississippi White-Tailed DeerScoty Hearst, Pedro M Palermo, Douglas M Watts, et al.
Pageof 4